Filing metadata

Accession number
0001140361-23-018515
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Apr 14, 2023
Reporting period
Apr 12, 2023
Description
Initial ownership

Explore SEC Filings Hub